GABITRIL

What this record means

The record shows that the mark “GABITRIL” is no longer active; it was cancelled on May 16 2009 because the owner, Cephalon, Inc., did not file a required declaration under Section 8. The mark had been registered on the Principal Register on September 24 2002 for the pharmaceutical preparation used to treat neurological disorders, class 005. Because the cancellation was due to a failure to maintain the registration, the mark no longer confers any legal protection, but the historical filing still indicates that the owner once claimed rights to that name in that specific class of goods. A similar name used for pharmaceutical products aimed at neurological disorders would create the closest record‑based concern, while use in unrelated industries would be farther from the scope shown. The supplied history contains no visible enforcement actions such as oppositions or court proceedings. For anyone thinking of a similar name, the record suggests a moderate risk of encountering prior claims in the same pharmaceutical area, but no active registration remains to enforce.